Aker BioMarine ASA: Extraordinary general meeting held - merger plan approved and condition for completion of cash offer fulfilled

Oslo, 17 August 2026: Reference is made to the stock exchange announcement published by Aker BioMarine ASA (the "Company") on 16 July 2026 regarding the announcement of a triangular merger pursuant to Chapter 13 of the Norwegian Public Limited Liability Companies Act between Aker BioMarine ASA and Aker Capital NewCo AS ("ACN"), with ACN as the surviving legal entity (the "Merger"), together with a related cash offer from Aker Capital AS to the shareholders of the Company (the "Cash Offer"). Notice of an extraordinary general meeting to approve the merger plan for the Merger was published on 17 July 2026.

The Company has today held the extraordinary general meeting. All items on the agenda were resolved in accordance with the proposals from the Board of Directors, including approval of the merger plan for the Merger. The minutes from the extraordinary general meeting are attached hereto and are also available on the Company's website www.akerbiomarine.com/AGM. The decision to approve the Merger will be filed with the Norwegian Register of Business Enterprises. Completion of the merger remains conditional upon customary closing conditions as described in the merger plan.

Completion of the Cash Offer was conditional upon approval of the Merger by the extraordinary general meeting in the Company. Settlement of the Cash Offer will take place no later than three trading days after todays approval of the Merger by the extraordinary general meeting in the Company.

For further information, please contact Lars Jacobsen, General Counsel Mobile: +47 906 05 306 Email: lars.jacobsen@akerbiomarine.com

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.